Public Profile

Huvepharma N.V.

Huvepharma N.V., a leading global player in the pharmaceutical industry, is headquartered in the Netherlands (NL) and operates extensively across Europe, North America, and Asia. Founded in 2001, the company has established itself as a key provider of innovative animal health products, focusing on the development and manufacturing of veterinary pharmaceuticals and nutritional solutions. With a diverse portfolio that includes antibiotics, vaccines, and feed additives, Huvepharma is renowned for its commitment to quality and efficacy. The company’s unique approach combines advanced research with a deep understanding of animal health needs, positioning it as a trusted partner in the livestock and aquaculture sectors. Notable achievements include significant market share growth and a reputation for excellence in product development, solidifying Huvepharma's status as a leader in the animal health market.

DitchCarbon Score

How does Huvepharma N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Huvepharma N.V.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Huvepharma N.V.'s reported carbon emissions

Huvepharma N.V., headquartered in the Netherlands, currently does not have publicly available carbon emissions data or specific reduction targets. As a company in the pharmaceutical industry, Huvepharma is likely aware of the growing importance of climate commitments and the need for transparency in emissions reporting. While no specific figures or initiatives are provided, the company may be exploring strategies to align with industry standards for sustainability and carbon footprint reduction. As the focus on climate action intensifies, it is essential for companies like Huvepharma to establish clear commitments and measurable targets to contribute to global efforts in mitigating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Huvepharma N.V.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Huvepharma N.V. is headquartered in NL, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Huvepharma N.V. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

DSM Nutritional Products AG

CH
Chemicals nec
Updated 27 days ago
DitchCarbon Score

Ceva Sante Animale

FR
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Virbac France SAS

FR
Chemicals nec
Updated 30 days ago
DitchCarbon Score

Boehringer Ingelheim Animal Health USA Inc.

US
Health and social work services (85)
Updated 6 days ago

Pahc

US
Health and social work services (85)
Updated 6 days ago

Vetoquinol SA

FR
Chemicals nec
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers